Search in:

Advanced search

Drug Design, Development and Therapy Volume 10, 2016 - Issue

Submit an article Journal homepage

Open access

204

Views

CrossRef citations to date

Altmetric

Original Research

Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach

Keyhaneh KarimiFaculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged, Hungary

Edina PallagiFaculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged, HungaryCorrespondence[email protected]

Piroska Szabó-RévészFaculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged, Hungary

Ildikó CsókaFaculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged, Hungary

Rita AmbrusFaculty of Pharmacy, Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Szeged, Hungary

Pages 3331-3343 | Published online: 12 Oct 2016

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

AndersonPJHistory of aerosol therapy liquid nebulization to MDIs to DPIsRespir Care20055091139115016122398
PubMedGoogle Scholar
PilcerGRosièreRTrainaKSebtiTVanderbistFAmighiKNew co-spray-dried tobramycin nanoparticles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patientsJ Pharm Sci201310261836184623568616
PubMed Web of Science ®Google Scholar
GelperinaSKisichKIsemanMDHeifetsLThe potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosisAm J Respir Crit Care Med2005172121487149016151040
PubMed Web of Science ®Google Scholar
WuLMiaoXShanZStudies on the spray dried lactose as carrier for dry powder inhalationAsian J Pharm Sci201496336341
Google Scholar
SungJCPulliamBLEdwardsDANanoparticles for drug delivery to the lungsTrends Biotechnol2007251256357017997181
PubMed Web of Science ®Google Scholar
YangYBajajNXuPOhnKTsifanskyMDYeoYDevelopment of highly porous large PLGA microparticles for pulmonary drug deliveryBiomaterials200930101947195319135245
PubMed Web of Science ®Google Scholar
CipollaDChanH-KInhaled antibiotics to treat lung infectionPharm Pat Anal20132564766324237172
PubMedGoogle Scholar
FawazFGuyotMLaguenyAMDevissaguetJPCiproflexacin-loaded polyisobutylcyanoacrylate nanoparticles: preparation and characterizationInt J Pharm1997154191203
Web of Science ®Google Scholar
MasadehMMAlzoubiKHKhabourOFAl-AzzamSICiprofloxacin-induced antibacterial activity is attenuated by phosphodiesterase inhibitorsCurr Ther Res Clin Exp201577141726649077
PubMedGoogle Scholar
ZhaoHLeYLiuHPreparation of microsized spherical aggregates of ultrafine ciprofloxacin particles for dry powder inhalation (DPI)Powder Technol20091948186
Web of Science ®Google Scholar
WeersJGMillerDPFormulation design of dry powders for inhalationJ Pharm Sci2015104103259328826296055
PubMed Web of Science ®Google Scholar
IslamNGladkiEDry powder inhalers (DPIs) – A review of device reliability and innovationInt J Pharm20083601–211118583072
PubMed Web of Science ®Google Scholar
StassHWeimannBNagelschmitzJRolinck-WerninghausCStaabDTolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation studyClin Ther201335101571158124054830
PubMed Web of Science ®Google Scholar
ZhouQShui Yee LeungSTangPParumasivamTHui LohZChanH-KInhaled formulations and pulmonary drug delivery systems for respiratory infectionsAdv Drug Deliv Rev201585839925451137
PubMed Web of Science ®Google Scholar
YuLXAmidonGKhanMAUnderstanding pharmaceutical quality by designAAPS J201416477178324854893
PubMed Web of Science ®Google Scholar
ICHICH Harmonised Tripartite GuidelinePharmaceutical Development Q8(R2)2009 Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdfAccessed September 30, 2016
Google Scholar
ICHICH Harmonised Tripartite GuidelineQuality Risk Manegement Q92005 Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdfAccessed September 30, 2016
Google Scholar
ICHICH Harmonised Tripartite GuidelinePharmaceutical Quality System Q102008 Available from: http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q10/Step4/Q10_Guideline.pdfAccessed September 30, 2016
Google Scholar
AmasyaGBadilliUAksuBTarimciNQuality by design case study 1: design of 5-fluorouracil loaded lipid nanoparticles by the W/O/W double emulsion – solvent evaporation methodEur J Pharm Sci2016849210226780593
PubMed Web of Science ®Google Scholar
WuXHayesDZwischenbergerJBKuhnRJMansourHMDesign and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalationDrug Des Devel Ther201375972
PubMed Web of Science ®Google Scholar
HealyAMAmaroMIPaluchKJTajberLDry powders for oral inhalation free of lactose carrier particlesAdv Drug Deliv Rev201475325224735676
PubMed Web of Science ®Google Scholar
FujiiHDecomposition analysis of green chemical technology inventions from 1971 to 2010 in JapanJ Clean Prod201611248354843
Web of Science ®Google Scholar
WuXZhangWHayesDMansourHMPhysicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol deliveryInt J Nanomedicine201381269128323569375
PubMed Web of Science ®Google Scholar
BelottiSRossiAColomboPSpray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product constructionInt J Pharm20144711–250751524886692
PubMedGoogle Scholar
HeijermanHWestermanEConwaySInhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensusJ Cyst Fibros20098529531519559658
PubMed Web of Science ®Google Scholar
AmbrusRSzabóBSzabó-RévészPDevelopment of dry powder carrier systems for pulmonary applicationFirst European Conference on Drug DeliveryApril 13–14, 2015Reims, France111
Google Scholar
LabirisNRDolovichMBPulmonary drug delivery. Part II: The role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medicationsBr J Clin Pharmacol200356660061214616419
PubMed Web of Science ®Google Scholar
OliveraMEManzoRHJungingerHEBiowaiver monographs for immediate release solid oral dosage forms: ciprofloxacin hydrochlorideJ Pharm Sci20111001223320602455
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Development of a microparticle-based dry powder inhalation formulation of ciprofloxacin hydrochloride applying the quality by design approach

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date